/Tag:MIRT

UAMS Myeloma Institute Director Gareth Morgan, M.D., Ph.D., Named ARA Scholar

Aug. 27, 2014 | Gareth Morgan, M.D., Ph.D., director of the University of Arkansas  for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy, was named an Arkansas Research Alliance (ARA) Scholar at a news conference today at the State Capitol.

By | August 27th, 2014|UAMS News, University News|0 Comments

Internationally Known Multiple Myeloma Expert Gareth Morgan, M.D., Ph.D., Coming to Lead UAMS Myeloma Institute

April 22, 2014 | World-renowned multiple myeloma researcher and clinician Gareth Morgan, M.D., Ph.D., today was named director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy (MIRT).

By | April 22nd, 2014|UAMS News, University News|0 Comments

UAMS Myeloma Institute Names Ammon to Lead Advisory Board

LITTLE ROCK – Carol A. Ammon, of Wilmington, Del., founder and retired chief executive officer and chairman of Endo Pharmaceuticals Inc., has been named chairman of the advisory board for the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS). <br /> <br />

By | December 7th, 2011|News Release, UAMS News|0 Comments

UAMS Myeloma Institute Treats 10,000th Patient

LITTLE ROCK – The internationally known Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) marked another milestone today, treatment of the 10,000th patient in its 22-year history.

By | November 9th, 2011|Media Contact - Taylor/Peel, UAMS News|0 Comments

Myeloma Clinical Trial Uses Natural Killer Cells

June 10, 2011 | A clinical trial on a first-of-its-kind treatment for multiple myeloma is now under way at the UAMS Myeloma Institute for Research and Therapy, using supercharged immune cells known as natural killer cells to attack cancer cells.

By | June 9th, 2011|UAMS News, University News|0 Comments